Everhart Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$661K Sell
27,433
-7,765
-22% -$203K 0.04% 234
2026
Q1
$988K Buy
35,198
+8,731
+33% +$232K 0.08% 176
2025
Q4
$659K Buy
26,467
+3,327
+14% +$83.9K 0.06% 223
2025
Q3
$590K Buy
23,140
+10,561
+84% +$261K 0.06% 229
2025
Q2
$305K Sell
12,579
-1,949
-13% -$45.5K 0.04% 286
2025
Q1
$368K Buy
14,528
+3,347
+30% +$87.6K 0.05% 253
2024
Q4
$297K Sell
11,181
-16,755
-60% -$454K 0.06% 257
2024
Q3
$808K Buy
27,936
+4,681
+20% +$137K 0.18% 128
2024
Q2
$651K Buy
23,255
+2,813
+14% +$77.4K 0.17% 128
2024
Q1
$567K Buy
+20,442
New +$567K 0.17% 132
2023
Q3
Sell
-14,227
Closed -$516K 227
2023
Q2
$516K Buy
14,227
+1,043
+8% +$40.6K 0.21% 93
2023
Q1
$532K Sell
13,184
-316
-2% -$13.6K 0.24% 84
2022
Q4
$684K Buy
13,500
+4,179
+45% +$200K 0.34% 61
2022
Q3
$408K Sell
9,321
-5,034
-35% -$245K 0.23% 86
2022
Q2
$753K Buy
14,355
+3,734
+35% +$190K 0.46% 42
2022
Q1
$550K Buy
10,621
+2,472
+30% +$128K 0.32% 66
2021
Q4
$481K Buy
8,149
+868
+12% +$43K 0.29% 62
2021
Q3
$313K Buy
+7,281
New +$323K 0.21% 82

Other funds holding PFE

Everhart Financial Group's PFE Position: Q2 2026 in Review

Everhart Financial Group reduced its Pfizer (PFE) stake by 22% in Q2 2026, selling an estimated $203K and leaving 27,433 shares worth $661K. The position accounts for 0.04% of the portfolio, ranked #234.

Everhart Financial Group first reported a position in PFE in Q3 2021 and has held it in 18 quarters since. The position peaked at $988K in Q1 2026. 705 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Everhart Financial Group held 27,433 shares of Pfizer worth $661K as of Q2 2026.
  • Everhart Financial Group sold 7,765 Pfizer shares in Q2 2026, an estimated $203K.
  • Pfizer made up 0.04% of Everhart Financial Group's portfolio in Q2 2026, its #234 holding.
  • Everhart Financial Group first reported a position in Pfizer in Q3 2021 and has held it in 18 quarters since.
  • Everhart Financial Group's Pfizer position peaked at $988K in Q1 2026.
  • 705 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.